COMP <GO>
LNTH vs LLY // EV/EBITDA & P/E VALUATION
Lantheus Holdings Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: LNTH 4
— LLY 10
▲ EV/EBITDA & P/E VALUATION LEADER: LNTH
LAST: $100.32 (+0.22%) • MKT CAP: $6.55B
valuation
18.0x
LAST: $1,373.70 (+6.63%) • MKT CAP: $1.29T
valuation
36.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LNTH VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LNTH | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 61.10% | 83.64% | -22.54 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 20.30% | 32.36% | -12.06 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.0x | 36.4x | -18.42 | LNTH | /valuation <GO> |
| Free Cash Flow Yield | 4.90% | 2.30% | +2.60 | LNTH | /fcf-yield <GO> |
| Operating Margin | 20.20% | 40.21% | -20.01 | LLY | /operating-margins <GO> |
| Net Profit Margin | 15.20% | 31.90% | -16.70 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 0.50% | 45.51% | -45.01 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.34 | 9.29 | -3.95 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.1 | 66.6 | -13.50 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.51 | +0.37 | LNTH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.0x | 26.3x | -0.25 | LNTH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.55B | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LNTH REV | LLY REV | LNTH GROSS % | LLY GROSS % | LNTH FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.54B | $65.18B | 61.1% | 83.0% | $320.8M | $16.81B |
| FY 2024 | $1.53B | $45.04B | 64.4% | 81.3% | $475.7M | $8.82B |
| FY 2023 | $1.30B | $34.12B | — | 79.3% | $246.9M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LNTH // BETA 0.88
LLY // BETA 0.51